Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Physics and Imaging in Radiation Oncology|March 11, 2026
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerMai L Ehmsen, Camilla S Byskov, Hanna R Mortensen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Design and pre-trial dose planning quality assurance of the Nordic trial of inhomogeneous dose escalated radiotherapy for patients with limited disease small cell lung cancer: NIELSSara Linde, Ditte S Møller, Mai-Britt Linaa, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Development of a treatment planning protocol for the multi-centre reirradiation CURE Lung trialLone Hoffmann, Mai-Britt Linaa, Mai Lykkegaard Ehmsen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2022
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centresLone Hoffmann, Hanna Mortensen, Muhammad Shamshad, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2025
Recommendations for radiotherapy quality assurance in clinical trialsCamilla Panduro Nielsen, Eva Samsøe, Birgitte Vrou Offersen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 TrialTine Schytte, Marianne M Knap, Charlotte Kristiansen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2024
Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenariosNicholas Hardcastle, Eliana Vasquez Osorio, Andrew Jackson, et al.International Journal of Radiation Oncology, Biology, Physics|July 9, 2023
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung TumorsSara Lindberg, Vitali Grozman, Kristin Karlsson, et al.International Journal of Radiation Oncology, Biology, Physics|January 14, 2026
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS CohortKristin Karlsson, Tiziana Rancati, Elias Lindbäck, et al.Lung Cancer (Amsterdam, Netherlands)|April 4, 2025
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS studySara Lindberg, Vitali Grozman, Kristin Karlsson, et al.Pageof 8